November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Medical Device Manufacturer Continues Push for Watchman Heart Implant Despite Past Regulatory Hurdles

❤️ Conditions & Care 1 min read 👁 2

Boston Scientific continues to heavily promote its Watchman heart implant following years of intense regulatory debate and a narrow initial FDA approval.

Medical Device Manufacturer Continues Push for Watchman Heart Implant Despite Past Regulatory Hurdles❤️Conditions & Care

Photo: statnews.com

Key points

  • Boston Scientific invested hundreds of millions to acquire the Watchman heart implant.
  • The device faced a years-long FDA review process before gaining initial approval.
  • Regulatory clearance was originally granted for a limited pool of patients.

Medical-device manufacturer Boston Scientific is maintaining a strong commercial push for its Watchman heart implant, a tiny device acquired over a decade ago for hundreds of millions of dollars. The path to market involved a prolonged evaluation by the Food and Drug Administration regarding its safety and clinical utility, culminating in an approval restricted to a specific patient population.

Despite the initial limitations set by federal regulators, the company developed strategies to expand the device's commercial footprint. The ongoing debate surrounding the implant highlights the complex intersection of medical device innovation, regulatory oversight, and corporate sales strategies within cardiology.

Healthcare professionals continue to evaluate the long-term data regarding the implant's role in stroke prevention for patients with atrial fibrillation. Experts advise patients to consult with their cardiologists to discuss individual treatment risks and benefits before considering specific medical devices.

Source statnews.com — statnews.com/2026/11/13/investigation-boston-scientific-watchman-ca… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.